Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2026 18:40 ET | Source: Sprout Health

Sprout Health NAD+ Injections — Compounding Status, Pharmacy Sourcing, and What Consumers Should Verify Before Any Telehealth NAD+ Enrollment in 2026

An independent verification briefing examining Sprout Health NAD+ compounding status, FDA classification, pricing, and enrollment considerations.
February 25, 2026 20:55 ET | Source: Sprout Health

Sprout Health GLP-1 Weight Loss in 2026 — Compounded Semaglutide Pricing, FDA Status, and What To Know Before Starting a Telehealth GLP-1 Program

Informational overview of Sprout Health's compounded GLP-1 telehealth model, semaglutide and tirzepatide pricing, and FDA status for 2026.
December 27, 2025 13:21 ET | Source: Sprout Health

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

Sprout Health lists prescription NAD+ injections at $149 first month through telehealth platform as consumer interest in compounded NAD+ grows.
December 26, 2025 16:33 ET | Source: Sprout Health

Best Peptides for Weight Loss 2026: Industry Analysis Examines Compounded GLP-1 Telehealth Access and Pricing Transparency

As 2026 approaches, an industry analysis examines GLP-1 telehealth access, medications, and disclosure standards shaping management decisions.